{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["NMDA receptor antagonist", "WJ-14", "antidepressant", "pharmacokinetic", "tissue distribution"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38254341", "DateCompleted": {"Year": "2024", "Month": "03", "Day": "15"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "15"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1002/bmc.5823"], "ArticleDate": [{"Year": "2024", "Month": "01", "Day": "22"}], "Journal": {"ISSN": "1099-0801", "JournalIssue": {"Volume": "38", "Issue": "4", "PubDate": {"Year": "2024", "Month": "Apr"}}, "Title": "Biomedical chromatography : BMC", "ISOAbbreviation": "Biomed Chromatogr"}, "ArticleTitle": "Pharmacokinetics, absolute bioavailability, and tissue distribution of WJ-14, a novel N-methyl-d-aspartate receptor antagonist, in rats by liquid chromatography-tandem mass spectrometry.", "Pagination": {"StartPage": "e5823", "MedlinePgn": "e5823"}, "Abstract": {"AbstractText": ["To circumvent the limitations of current antidepressants, WJ-14, a novel N-methyl-d-aspartate receptor antagonist, was synthesized and demonstrated to have remarkable efficiency in the treatment of depression. To illustrate the pharmacokinetics, absolute bioavailability, and tissue distribution of WJ-14 in rats, a rapid and sensitive liquid chromatography-tandem mass spectrometry-based analytical method was developed and validated for the separation and detection of WJ-14 in both plasma and tissue samples. After oral administration, WJ-14 was rapidly absorbed into the blood with time to reach the maximum plasma concentration (T<sub>max</sub> ) within 0.28\u2009h and quickly eliminated with clearance (Cl) exceeding 6.80\u00a0L/h/kg and elimination half-life (t<sub>1/2</sub> ) within 2.69\u2009h. No obvious accumulation was found with mean residencetime (MRT) within 4.10\u2009h. Tissue distribution revealed that WJ-14 was extensively distributed in the main tissues of rats, and massive amounts of WJ-14 were distributed in the liver. Extensive distribution and quick elimination led to extremely low absolute bioavailability of WJ-14 (1.91% of 8.33\u2009mg/kg and 3.30% of 24.99\u2009mg/kg). WJ-14 was detected in the brain only 0.083\u2009h after oral administration, which is crucial for a rapid-onset antidepressant candidate. In addition, WJ-14 likely exhibited a non-linear pharmacokinetic process at dosages of 8.33 and 24.99\u2009mg/kg. The findings may provide valuable information for subsequent studies on WJ-14."], "CopyrightInformation": "\u00a9 2024 John Wiley & Sons Ltd."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Zhejiang Provincial People's Hospital Bijie Hospital (the First People's Hospital of Bijie), Bijie, China."}], "LastName": "Huang", "ForeName": "Weiyin", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Zunyi Medicinal University, Zunyi, China."}], "LastName": "Zhang", "ForeName": "Yan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province, Guiyang, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}], "LastName": "Yang", "ForeName": "Lishou", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Pharmacy Center, Department of Pharmacy, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China."}], "LastName": "Zhang", "ForeName": "Yiwen", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Zhejiang Provincial People's Hospital Bijie Hospital (the First People's Hospital of Bijie), Bijie, China."}], "LastName": "Cheng", "ForeName": "Lei", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Zhejiang Provincial People's Hospital Bijie Hospital (the First People's Hospital of Bijie), Bijie, China."}], "LastName": "Deng", "ForeName": "Yan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Zhejiang Provincial People's Hospital Bijie Hospital (the First People's Hospital of Bijie), Bijie, China."}], "LastName": "Wu", "ForeName": "Xinyu", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Zhejiang Provincial People's Hospital Bijie Hospital (the First People's Hospital of Bijie), Bijie, China."}], "LastName": "Wang", "ForeName": "Tingting", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Research Center of Guizhou Province, Guiyang, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}], "LastName": "Yang", "ForeName": "Xiaosheng", "Initials": "X"}, {"Identifier": ["0000-0002-7070-2564"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Zhejiang Provincial People's Hospital Bijie Hospital (the First People's Hospital of Bijie), Bijie, China."}, {"Identifier": [], "Affiliation": "The Sixth Affiliated Hospital, School of Medicine, South China University of Technology & Nanhai District People's Hospital of Foshan, Foshan, China."}], "LastName": "Ye", "ForeName": "Linhu", "Initials": "L"}], "GrantList": [{"GrantID": "81860609", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "QKHZC [2021] General 424", "Agency": "Project of Guizhou Science and Technology Platform and Talent Team", "Country": ""}, {"GrantID": "[2023] 61", "Agency": "Association Fund Project of the Science and Technology Department of Bijie Prefecture", "Country": ""}, {"Agency": "Foshan \"Fourteen-Five\" Key Medical Specialty Construction Project", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Biomed Chromatogr", "NlmUniqueID": "8610241", "ISSNLinking": "0269-3879"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Receptors, N-Methyl-D-Aspartate"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Biological Availability"}, {"QualifierName": [], "DescriptorName": "Tissue Distribution"}, {"QualifierName": [], "DescriptorName": "Receptors, N-Methyl-D-Aspartate"}, {"QualifierName": ["methods"], "DescriptorName": "Tandem Mass Spectrometry"}, {"QualifierName": ["methods"], "DescriptorName": "Chromatography, Liquid"}, {"QualifierName": [], "DescriptorName": "Administration, Oral"}, {"QualifierName": ["methods"], "DescriptorName": "Chromatography, High Pressure Liquid"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Adell, A. (2020). Brain NMDA receptors in schizophrenia and depression. Biomolecules, 10(6), 947. https://doi.org/10.3390/biom10060947"}, {"Citation": "Chen, Y. M., Lin, C. H., & Lane, H. Y. (2020). Survey of NMDA receptor-related biomarkers for depression. Current Pharmaceutical Design, 26(2), 228-235. https://doi.org/10.2174/1381612826666200122155206"}, {"Citation": "Daly, E. J., Singh, J. B., Fedgchin, M., Cooper, K., Lim, P., Shelton, R. C., & Drevets, W. C. (2018). Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: A randomized clinical trial. JAMA Psychiatry, 75(2), 139-148. https://doi.org/10.1001/jamapsychiatry.2017.3739"}, {"Citation": "Domino, E. F. (2010). Taming the ketamine tiger. Anesthesiology, 113(3), 678-684. https://doi.org/10.1097/ALN.0b013e3181ed09a2"}, {"Citation": "Espadinha, M., Viejo, L., Lopes, R. M. R. M., Herrera-Arozamena, C., Molins, E., dos Santos, D. J. V. A., & Santos, M. M. M. (2020). Identification of tetracyclic lactams as NMDA receptor antagonists with potential application in neurological disorders. European Journal of Medicinal Chemistry, 194, 112242. https://doi.org/10.1016/j.ejmech.2020.112242"}, {"Citation": "FDA. (2018). Guidance for industry: Bioanalytical method validation. https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf"}, {"Citation": "Huang, Y., Wang, Y., Wang, H., Liu, Z., Yu, X., Yan, J., Yu, Y., Kou, C., Xu, X., Lu, J., Wang, Z., He, S., Xu, Y., He, Y., Li, T., Guo, W., Tian, H., Xu, G., Xu, X., \u2026 Wu, Y. (2019). Prevalence of mental disorders in China: A cross-sectional epidemiological study. The Lancet. Psychiatry, 6(3), 211-224. https://doi.org/10.1016/S2215-0366(18)30511-X"}, {"Citation": "Jha, M. K., Williamson, D. J., Magharehabed, G., Turkoz, I., Daly, E. J., & Trivedi, M. H. (2023). Intranasal esketamine effectively treats treatment-resistant depression in adults regardless of baseline irritability. Journal of Affective Disorders, 321, 153-160. https://doi.org/10.1016/j.jad.2022.10.020"}, {"Citation": "Marwaha, S., Palmer, E., Suppes, T., Cons, E., Young, A. H., & Upthegrove, R. (2023). Novel and emerging treatments for major depression. Lancet, 401(10371), 141-153. https://doi.org/10.1016/S0140-6736(22)02080-3"}, {"Citation": "Meshkat, S., Rosenblat, J. D., Ho, R. C., Rhee, T. G., Cao, B., Ceban, F., Danayan, K., Chisamore, N., Vincenzo, J. D. D., & McIntyre, R. S. (2022). Ketamine use in pediatric depression: A systematic review. Psychiatry Research, 317, 114911. https://doi.org/10.1016/j.psychres.2022.114911"}, {"Citation": "Morris, P. J., Burke, R. D., Sharma, A. K., Lynch, D. C., Lemke-Boutcher, L. E., Mathew, S., Elayan, I., Rao, D. B., Gould, T. D., Zarate, C. A. Jr., Zanos, P., Moaddel, R., & Thomas, C. J. (2021). A comparison of the pharmacokinetics and NMDAR antagonism-associated neurotoxicity of ketamine, (2R,6R)-hydroxynorketamine and MK-801. Neurotoxicology and Teratology, 87, 106993. https://doi.org/10.1016/j.ntt.2021.106993"}, {"Citation": "Nakajima, S., Suzuki, T., Watanabe, K., Kashima, H., & Uchida, H. (2010). Accelerating response to antidepressant treatment in depression: A review and clinical suggestions. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 34(2), 259-264. https://doi.org/10.1016/j.pnpbp.2009.12.001"}, {"Citation": "Pochwat, B., Nowak, G., & Szewczyk, B. (2019). An update on NMDA antagonists in depression. Expert Review of Neurotherapeutics, 19(11), 1055-1067. https://doi.org/10.1080/14737175.2019.1643237"}, {"Citation": "Richardson, B., MacPherson, A., & Bambico, F. (2022). Neuroinflammation and neuroprogression in depression: Effects of alternative drug treatments. Brain, Behavior, & Immunity - Health, 26, 100554. https://doi.org/10.1016/j.bbih.2022.100554"}, {"Citation": "Swainson, J., Thomas, R. K., Archer, S., Chrenek, C., MacKay, M. A., Baker, G., Dursun, S., Klassen, L. J., Chokka, P., & Demas, M. L. (2019). Esketamine for treatment resistant depression. Expert Review of Neurotherapeutics, 19(10), 899-911. https://doi.org/10.1080/14737175.2019.1640604"}, {"Citation": "Wang, Y. B., Song, N. N., Ding, Y. Q., & Zhang, L. (2023). Neural plasticity and depression treatment. IBRO Neuroscience Reports, 14, 160-184. https://doi.org/10.1016/j.ibneur.2022.09.001"}, {"Citation": "WHO. (2021). Depression. Retrieved September 13, 2023, from https://www.who.int/news-room/fact-sheets/detail/depression"}, {"Citation": "Williams, N. R., & Schatzberg, A. F. (2016). NMDA antagonist treatment of depression. Current Opinion in Neurobiology, 36, 112-117. https://doi.org/10.1016/j.conb.2015.11.001"}, {"Citation": "Witkin, J. M., Cerne, R., Newman, A. H., Izenwasser, S., Smith, J. L., & Tortella, F. C. (2021). N-Substituted-3-alkoxy-derivatives of dextromethorphan are functional NMDA receptor antagonists in vivo: Evidence from an NMDA-induced seizure model in rats. Pharmacology Biochemistry and Behavior, 203, 173154. https://doi.org/10.1016/j.pbb.2021.173154"}, {"Citation": "Xie, Y., Dou, Y., & Tang, Y. (2020). Intranasal delivery of rapid-onset antidepressants: A new trend of treating major depressive disorder. Journal of Chinese Pharmaceutical Sciences, 29(8), 515-527. https://doi.org/10.5246/jcps.2020.08.049"}, {"Citation": "Yang, L., Liu, H., Wang, E., Liu, H., Liu, H., Zhou, L., Deng, T., Pan, X., Hu, Z., & Yang, X. (2023). Design, synthesis and evaluation of novel 1-phenyl-pyrrolo[1,2-b]isoquinolin-3-one derivatives as antagonists for the glycine binding site of the NMDA receptor. European Journal of Medicinal Chemistry, 258, 115624. https://doi.org/10.1016/j.ejmech.2023.115624"}, {"Citation": "Yang, L., Yang, Q., Wang, E., Yang, J., Li, Q., Cao, J., Wang, L., Liao, X., Yang, Y., & Yang, X. (2022). Synthesis of novel 1-phenyl-benzopyrrolizidin-3-one derivatives and evaluation of their cytoneuroprotective effects against NMDA-induced injury in PC12 cells. Bioorganic & Medicinal Chemistry, 59, 116675. https://doi.org/10.1016/j.bmc.2022.116675"}, {"Citation": "Yang, X., Yang, L., Chen, F., Yang, J., Wang, Y., Luo, Z., & Yan, Y. (2020). 1-Phenyl-pyrrolo[1,2-b]isoquinolines-3-ketone, preparing method and application (CN112094267A). CN patent."}], "Title": "REFERENCES"}], "History": [{"Year": "2023", "Month": "12", "Day": "7"}, {"Year": "2023", "Month": "8", "Day": "7"}, {"Year": "2023", "Month": "12", "Day": "12"}, {"Year": "2024", "Month": "3", "Day": "15", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "1", "Day": "23", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "1", "Day": "23", "Hour": "0", "Minute": "53"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38254341", "10.1002/bmc.5823"]}}]}